SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emke Maréchal, Benjamin Denoiseux, Ellen Thys, David Crosiers, Barbara Pickut, Patrick Cras, Impulse control disorders in Parkinson’s disease: an overview from neurobiology to treatment, Journal of Neurology, 2014,

    CrossRef

  2. 2
    Kangdi Zhu, Jacobus J. van Hilten, Johan Marinus, Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG, Parkinsonism & Related Disorders, 2014, 20, 9, 980

    CrossRef

  3. 3
    Lonneke M.L. de Lau, Dagmar Verbaan, Johan Marinus, Jacobus J. van Hilten, Survival in Parkinson's disease. Relation with motor and non-motor features, Parkinsonism & Related Disorders, 2014, 20, 6, 613

    CrossRef

  4. 4
    James M. Shine, Glenda M. Halliday, Moran Gilat, Elie Matar, Samuel J. Bolitho, Maria Carlos, Sharon L. Naismith, Simon J.G. Lewis, The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease, Human Brain Mapping, 2014, 35, 5
  5. 5
    Fabrizio Stocchi, Olivier Rascol, Alain Destee, Nobutaka Hattori, Robert A. Hauser, Anthony E. Lang, Werner Poewe, Mark Stacy, Eduardo Tolosa, Haitao Gao, Jennifer Nagel, Martin Merschhemke, Ana Graf, Christopher Kenney, Claudia Trenkwalder, AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study, Movement Disorders, 2013, 28, 13
  6. 6
    D.H. Hepp, C.C. da Hora, T. Koene, B.M. Uitdehaag, O.A. van den Heuvel, M. Klein, W.D. van de Berg, H.W. Berendse, E.M. Foncke, Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients, Parkinsonism & Related Disorders, 2013, 19, 9, 795

    CrossRef

  7. 7
    Pablo Martinez-Martin, Instruments for holistic assessment of Parkinson’s disease, Journal of Neural Transmission, 2013, 120, 4, 559

    CrossRef

  8. 8
    Asako Yoritaka, Yasushi Shimo, Masashi Takanashi, Jiro Fukae, Taku Hatano, Toshiki Nakahara, Nobukazu Miyamato, Takao Urabe, Hideo Mori, Nobutaka Hattori, Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks, Parkinsonism & Related Disorders, 2013, 19, 8, 725

    CrossRef

  9. 9
    Kangdi Zhu, Jacobus J. Hilten, Hein Putter, Johan Marinus, Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study, Movement Disorders, 2013, 28, 6
  10. 10
    Rubén Armañanzas, Concha Bielza, Kallol Ray Chaudhuri, Pablo Martinez-Martin, Pedro Larrañaga, Unveiling relevant non-motor Parkinson's disease severity symptoms using a machine learning approach, Artificial Intelligence in Medicine, 2013, 58, 3, 195

    CrossRef

  11. 11
    Pablo Martinez-Martin, Belen Frades-Payo, Luis Agüera-Ortiz, Angel Ayuga-Martinez, A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease: first psychometric approach, Journal of Neurology, 2012, 259, 11, 2299

    CrossRef

  12. 12
    James M. Shine, Glenda H. Halliday, Mayra Carlos, Sharon L. Naismith, Simon J.G. Lewis, Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm, Movement Disorders, 2012, 27, 4
  13. 13
    J. Janzen, D. van ‘t Ent, A. W. Lemstra, H. W. Berendse, F. Barkhof, E. M. J. Foncke, The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study, Journal of Neurology, 2012, 259, 1, 147

    CrossRef

  14. 14
    P. Martinez-Martin, C. Falup-Pecurariu, C. Rodriguez-Blazquez, M. Serrano-Dueñas, F.J. Carod Artal, J.M. Rojo Abuin, D. Aarsland, Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria, Parkinsonism & Related Disorders, 2011, 17, 8, 621

    CrossRef

  15. 15
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  16. 16
    Javier Virués-Ortega, Carmen Rodríguez-Blázquez, Federico Micheli, Francisco Javier Carod-Artal, Marcos Serrano-Dueñas, Pablo Martínez-Martín, Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages, Movement Disorders, 2010, 25, 10
  17. 17
    Philip O. Buck, Holly Trautman, Jamie Clark, Scales for Assessing Nonmotor Symptom Severity Changes in Parkinson's Disease Patients With Symptom Fluctuations, International Journal of Neuroscience, 2010, 120, 8, 523

    CrossRef

  18. 18
    Martine Visser, Dagmar Verbaan, Stephanie Van Rooden, Johan Marinus, Johannes Van Hilten, Anne Stiggelbout, A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's Disease, Value in Health, 2009, 12, 2
  19. 19
    Maria G. Macedo, Dagmar Verbaan, Yue Fang, Stephanie M. van Rooden, Martine Visser, Burcu Anar, Antonella Uras, Justus L. Groen, Patrizia Rizzu, Jacobus J. van Hilten, Peter Heutink, Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease, Movement Disorders, 2009, 24, 2
  20. 20
    Josè Martin Rabey, Hallucinations and psychosis in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S105

    CrossRef

  21. 21
    Stephanie M. van Rooden, Martine Visser, Dagmar Verbaan, Johan Marinus, Jacobus J. van Hilten, Motor patterns in Parkinson's disease: A data-driven approach, Movement Disorders, 2009, 24, 7
  22. 22
    Dagmar Verbaan, Stephanie M. van Rooden, Martine Visser, Johan Marinus, Murat Emre, Jacobus J. van Hilten, Psychotic and compulsive symptoms in Parkinson's disease, Movement Disorders, 2009, 24, 5
  23. 23
    M. Visser, S. M. van Rooden, D. Verbaan, J. Marinus, A. M. Stiggelbout, J. J. van Hilten, A comprehensive model of health-related quality of life in Parkinson’s disease, Journal of Neurology, 2008, 255, 10, 1580

    CrossRef

  24. 24
    William Stamey, Joseph Jankovic, Impulse Control Disorders and Pathological Gambling in Patients With Parkinson Disease, The Neurologist, 2008, 14, 2, 89

    CrossRef

  25. 25
    Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Belen Frades-Payo, Specific patient-reported outcome measures for Parkinson’s disease: analysis and applications, Expert Review of Pharmacoeconomics & Outcomes Research, 2008, 8, 4, 401

    CrossRef